{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T23:41:52Z","timestamp":1766360512516,"version":"3.48.0"},"reference-count":20,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. A rare but severe complication is haemophagocytic lymphohistiocytosis (HLH), an aggressive syndrome of excessive immune activation. Managing both conditions is particularly challenging in patients with multiple comorbidities. A 78-year-old male with a complex history, including myasthenia gravis and chronic kidney disease, was admitted with sepsis. Investigations confirmed infection with methicillin-resistant\n                    <jats:italic>Staphylococcus aureus<\/jats:italic>\n                    and human herpesvirus 8. He was subsequently diagnosed with HLH based on bone marrow findings of haemophagocytosis and elevated soluble CD25 levels. He was treated with a combination of antibiotics, immunomodulatory agents, and supportive care. After 21 days of treatment, the patient\u2019s condition improved significantly. This case highlights the importance of early recognition and timely intervention in the management of sepsis and HLH in patients with multiple comorbidities. A multidisciplinary approach and individualised treatment strategies are crucial for improving patient outcomes.\n                  <\/jats:p>","DOI":"10.1515\/biol-2025-1186","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:57:14Z","timestamp":1761551834000},"source":"Crossref","is-referenced-by-count":0,"title":["Sepsis complicated by haemophagocytic lymphohistiocytosis triggered by methicillin-resistant\n                    <i>Staphylococcus aureus<\/i>\n                    and human herpesvirus 8 in an immunocompromised elderly patient: A case report"],"prefix":"10.1515","volume":"20","author":[{"given":"Min","family":"He","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Shishi General Hospital , Fujian Province , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanni","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Shishi General Hospital , Fujian Province , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanbo","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Shishi General Hospital , Fujian Province , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongqin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Shishi General Hospital , Fujian Province , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanrong","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Shishi General Hospital , Fujian Province , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaoling","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Shishi General Hospital , Fujian Province , China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"2025122123392370802_j_biol-2025-1186_ref_001","doi-asserted-by":"crossref","unstructured":"Williams B, Zou L, Pittet JF, Chao W. Sepsis-induced coagulopathy: a comprehensive narrative review of pathophysiology, clinical presentation, diagnosis, and management strategies. Anesth Analg. 2024;138(4):696\u2013711. 10.1213\/ANE.0000000000006888, Epub 2024 Feb 7 PMID: 38324297; PMCID: PMC10916756.","DOI":"10.1213\/ANE.0000000000006888"},{"key":"2025122123392370802_j_biol-2025-1186_ref_002","doi-asserted-by":"crossref","unstructured":"Sztajnbok F, Fonseca AR, Campos LR, Lino K, Rodrigues MCF, Silva RM, et al. Hemophagocytic lymphohistiocytosis and macrophage activation syndrome: two rare sides of the same devastating coin. Adv Rheumatol. 2024;64(1):28. 10.1186\/s42358-024-00370-2, PMID: 38627860.","DOI":"10.1186\/s42358-024-00370-2"},{"key":"2025122123392370802_j_biol-2025-1186_ref_003","doi-asserted-by":"crossref","unstructured":"Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200\u201311. 10.1016\/S0140-6736(19)32989-7, PMID: 31954465; PMCID: PMC6970225.","DOI":"10.1016\/S0140-6736(19)32989-7"},{"key":"2025122123392370802_j_biol-2025-1186_ref_004","doi-asserted-by":"crossref","unstructured":"Bauer M, Gerlach H, Vogelmann T, Preissing F, Stiefel J, Adam D. Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019- results from a systematic review and meta-analysis. Crit Care. 2020;24(1):239. 10.1186\/s13054-020-02950-2, PMID: 32430052; PMCID: PMC7236499.","DOI":"10.1186\/s13054-020-02950-2"},{"key":"2025122123392370802_j_biol-2025-1186_ref_005","doi-asserted-by":"crossref","unstructured":"Barichello T, Generoso JS, Singer M, Dal-Pizzol F. Biomarkers for sepsis: more than just fever and leukocytosis-a narrative review. Crit Care2022 26(1):14. 10.1186\/s13054-021-03862-5, PMID: 34991675; PMCID: PMC8740483.","DOI":"10.1186\/s13054-021-03862-5"},{"key":"2025122123392370802_j_biol-2025-1186_ref_006","doi-asserted-by":"crossref","unstructured":"Hayden A, Park S, Giustini D, Lee AY, Chen LY. Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: A systematic scoping review. Blood Rev. 2016;30(6):411\u201320. 10.1016\/j.blre.2016.05.001, Epub 2016 May 20 PMID: 27238576.","DOI":"10.1016\/j.blre.2016.05.001"},{"key":"2025122123392370802_j_biol-2025-1186_ref_007","doi-asserted-by":"crossref","unstructured":"Canna SW, Marsh RA. Pediatric hemophagocytic lymphohistiocytosis. Blood. 2020;135(16):1332\u201343. 10.1182\/blood.2019000936, PMID: 32107531; PMCID: PMC8212354.","DOI":"10.1182\/blood.2019000936"},{"key":"2025122123392370802_j_biol-2025-1186_ref_008","doi-asserted-by":"crossref","unstructured":"Nasa P, Juneja D, Singh O. Severe sepsis and septic shock in the elderly: An overview. World J Crit Care Med. 2012;1(1):23\u201330. 10.5492\/wjccm.v1.i1.23","DOI":"10.5492\/wjccm.v1.i1.23"},{"key":"2025122123392370802_j_biol-2025-1186_ref_009","doi-asserted-by":"crossref","unstructured":"Martin GS, Mannino DM, Moss M. The effect of age on the development and outcome of adult sepsis. Crit Care Med. 2006;34(1):15\u201321. 10.1097\/01.ccm.0000194535.82812.ba, PMID: 16374151.","DOI":"10.1097\/01.CCM.0000194535.82812.BA"},{"key":"2025122123392370802_j_biol-2025-1186_ref_010","doi-asserted-by":"crossref","unstructured":"Fardet L, Galicier L, Lambotte O, Marzac C, Aumont C, Chahwan D, et al. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol. 2014;66(9):2613\u201320. 10.1002\/art.38690, PMID: 24782338.","DOI":"10.1002\/art.38690"},{"key":"2025122123392370802_j_biol-2025-1186_ref_011","doi-asserted-by":"crossref","unstructured":"Montgomery RR, Shaw AC. Paradoxical changes in innate immunity in aging: recent progress and new directions. J Leukoc Biol. 2015 Dec;98(6):937\u201343. 10.1189\/jlb.5MR0315-104R, Epub 2015 Jul 17. PMID: 26188078; PMCID: PMC4661037.","DOI":"10.1189\/jlb.5MR0315-104R"},{"key":"2025122123392370802_j_biol-2025-1186_ref_012","doi-asserted-by":"crossref","unstructured":"Bangaru S, Strickland A, Cavuoti D, Shah N. HHV-8-associated haemophagocytic lymphohistiocytosis in a patient with advanced AIDS. BMJ Case Rep. 2017;2017:bcr2017222382. 10.1136\/bcr-2017-222382, PMID: 29275390; PMCID: PMC5780605.","DOI":"10.1136\/bcr-2017-222382"},{"key":"2025122123392370802_j_biol-2025-1186_ref_013","doi-asserted-by":"crossref","unstructured":"Crayne CB, Albeituni S, Nichols KE, Cron RQ. The immunology of macrophage activation syndrome. Front Immunol. 2019;10:119. 10.3389\/fimmu.2019.00119, PMID: 30774631; PMCID: PMC6367262.","DOI":"10.3389\/fimmu.2019.00119"},{"key":"2025122123392370802_j_biol-2025-1186_ref_014","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181\u2013247. 10.1007\/s00134-021-06506-y, Epub 2021 Oct 2 . PMID: 34599691; PMCID: PMC8486643."},{"key":"2025122123392370802_j_biol-2025-1186_ref_015","doi-asserted-by":"crossref","unstructured":"Uldrick TS, Wang V, O\u2019Mahony D, Aleman K, Wyvill KM, Marshall V, et al. An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease. Clin Infect Dis. 2010;51(3):350\u20138. 10.1086\/654798IF: 7.3 Q1, PMID: 20583924; PMCID: PMC2946207.","DOI":"10.1086\/654798"},{"key":"2025122123392370802_j_biol-2025-1186_ref_016","doi-asserted-by":"crossref","unstructured":"Korytkowski MT, Muniyappa R, Antinori-Lent K, Donihi AC, Drincic AT, Hirsch IB, et al. Management of hyperglycemia in hospitalized adult patients in non-critical care settings: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2022;107(8):2101\u201328. 10.1210\/clinem\/dgac278, PMID: 35690958; PMCID: PMC9653018.","DOI":"10.1210\/clinem\/dgac278"},{"key":"2025122123392370802_j_biol-2025-1186_ref_017","doi-asserted-by":"crossref","unstructured":"Hines MR, von Bahr Greenwood T, Beutel G, Beutel K, Hays JA, Horne A, et al. Consensus-Based guidelines for the recognition, diagnosis, and management of hemophagocytic lymphohistiocytosis in critically Ill children and adults. Crit Care Med. 2022;50(5):860\u201372. 10.1097\/CCM.0000000000005361, Epub 2021 Oct 5 . PMID: 34605776.","DOI":"10.1097\/CCM.0000000000005361"},{"key":"2025122123392370802_j_biol-2025-1186_ref_018","doi-asserted-by":"crossref","unstructured":"Volkow P, Chavez Galan L, Ramon-Luing L, Cruz-Velazquez J, Cornejo-Juarez P, Sada-Ovalle I, et al. Impact of valganciclovir therapy on severe IRIS-Kaposi Sarcoma mortality: An open-label, parallel, randomized controlled trial. PLoS One. 2023;18(5):e0280209. 10.1371\/journal.pone.0280209IF: 2.6 Q2, PMID: 37195970; PMCID: PMC10191357.","DOI":"10.1371\/journal.pone.0280209"},{"key":"2025122123392370802_j_biol-2025-1186_ref_019","doi-asserted-by":"crossref","unstructured":"Wang L, Zhang X, Huang B, Hou Y, Liu X, Jiao H. Ruxolitinib as an effective treatment for hemophagocytic lymphohistiocytosis secondary to SARS-Cov-2 infection: a case report. Infect Drug Resist. 2023;16:2467\u201373. 10.2147\/IDR.S384035, PMID: 37131454; PMCID: PMC10149062.","DOI":"10.2147\/IDR.S384035"},{"key":"2025122123392370802_j_biol-2025-1186_ref_020","doi-asserted-by":"crossref","unstructured":"Bergsten E, Horne A, Aric\u00f3 M, Astigarraga I, Egeler RM, Filipovich AH, et al. Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study. Blood. 2017;130(25):2728\u201338. 10.1182\/blood-2017-06-788349, Epub 2017 Sep 21. PMID: 28935695; PMCID: PMC5785801","DOI":"10.1182\/blood-2017-06-788349"}],"container-title":["Open Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/biol-2025-1186\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/biol-2025-1186\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T23:40:31Z","timestamp":1766360431000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/biol-2025-1186\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,1]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,3,6]]},"published-print":{"date-parts":[[2025,3,6]]}},"alternative-id":["10.1515\/biol-2025-1186"],"URL":"https:\/\/doi.org\/10.1515\/biol-2025-1186","relation":{},"ISSN":["2391-5412"],"issn-type":[{"type":"electronic","value":"2391-5412"}],"subject":[],"published":{"date-parts":[[2025,1,1]]},"article-number":"20251186"}}